SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-004319
Filing Date
2021-02-04
Accepted
2021-02-04 16:10:52
Documents
62
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q arwr-10q_20201231.htm   iXBRL 10-Q 1562574
2 EX-10.1 arwr-ex101_863.htm EX-10.1 1306875
3 EX-10.2 arwr-ex102_50.htm EX-10.2 188588
4 EX-10.3 arwr-ex103_51.htm EX-10.3 75593
5 EX-10.4 arwr-ex104_52.htm EX-10.4 41604
6 EX-31.1 arwr-ex311_7.htm EX-31.1 10485
7 EX-31.2 arwr-ex312_6.htm EX-31.2 10930
8 EX-32.1 arwr-ex321_8.htm EX-32.1 6316
9 EX-32.2 arwr-ex322_9.htm EX-32.2 6563
  Complete submission text file 0001564590-21-004319.txt   8087307

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA arwr-20201231.xsd EX-101.SCH 46382
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arwr-20201231_cal.xml EX-101.CAL 44530
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arwr-20201231_def.xml EX-101.DEF 157177
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE arwr-20201231_lab.xml EX-101.LAB 381308
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arwr-20201231_pre.xml EX-101.PRE 292120
15 EXTRACTED XBRL INSTANCE DOCUMENT arwr-10q_20201231_htm.xml XML 1108150
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38042 | Film No.: 21591254
SIC: 2834 Pharmaceutical Preparations